Kindeva Drug Delivery L.P.
USPTO PatentsView assignee record - 33 granted patents across 13 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Kindeva ranks #9,540 of 49,997 tracked US assignees by granted-patent volume, with 33 patents across 13 technology areas.
- #9,540
- of 49,997 US assignees by volume
- Top 24%
- by Innovation Score (44.9/100)
- 17.6
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R9540 · US Corporation #9,540 · 33 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-SMALL 33 grants
- UPPER-Q #9,540/49,997
- PHOTO-FINISH Kilopass Technology
- CPC-FOCUS A61M · 13 areas
- INNOV-PAR 44.9/100
- CLAIMS-RICH 17.6 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2020–2025 · 6y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Kilopass Technology, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Kindeva’s 44.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Kindeva
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Bidstack Group · near
Bidstack Group · near
45 score
- Kindeva Drug Delivery · this assignee
Kindeva Drug Delivery · this assignee
45 score
- Kirchhoff Automotive… · near
Kirchhoff Automotive… · near
45 score
- PolyPlus Battery · near
PolyPlus Battery · near
45 score
- Kaeser Kompressoren SE · near
Kaeser Kompressoren SE · near
45 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Kindeva's Innovation Score is 44.9/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Kindeva?
Each dot is one of Kindeva’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Kindeva’s own 17.6 claims/patent is ABOVE the 10.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Kindeva's grants concentrate
Kindeva Drug Delivery L.P. is a focused PatentsView assignee: 13 CPC subclasses with 93.9% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2022 (9 grants) versus a trough of 2 in 2024. By volume, Kindeva sits between Kind Consumer Limited and Ledlenser GMBH & Co. KG.
Kindeva's three-year grant acceleration
Kindeva Drug Delivery L.P. shows 17 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Kindeva's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Kind Consumer
Kind Consumer Limited
33 patents
- Kokusai Keisokuki
Kokusai Keisokuki Kabushiki Kaisha
33 patents
- Korea Institute O…
Korea Institute OF Radiological & Medical Sciences
33 patents
- Kilopass Technolo…
Kilopass Technology, Inc.
33 patents
- Knuedge Incorpora…
KnuEdge Incorporated
33 patents
- LA Jolla Institut…
LA Jolla Institute FOR Allergy AND Immunology
33 patents
- LED Labs sp z o o
LED Labs sp. z o.o
33 patents
- Ledlenser & KG
Ledlenser GMBH & Co. KG
33 patents
- Kindeva Drug Deli… ◀
Kindeva Drug Delivery L.P.
33 patents
What this shows Kindeva holds 33 patents at rank #9,541, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Kindeva
By rank, the assignees closest to #9,541 in granted patent volume.
- Kind Consumer Limited #9,537 · 33 patents
- Kokusai Keisokuki Kabushiki Kaisha #9,538 · 33 patents
- Korea Institute OF Radiological & Medical Sciences #9,539 · 33 patents
- Kilopass Technology, Inc. #9,540 · 33 patents
- KnuEdge Incorporated #9,542 · 33 patents
- LA Jolla Institute FOR Allergy AND Immunology #9,543 · 33 patents
- LED Labs sp. z o.o #9,544 · 33 patents
- Ledlenser GMBH & Co. KG #9,545 · 33 patents
Leaders in A61M (Devices FOR Introducing Media Into)
Other assignees with the most granted patents in Kindeva's primary technology class.
- Becton, Dickinson and Company 1,249 in class
- Sanofi-Aventis Deutschland GMBH 1,159 in class
- Boston Scientific Scimed, Inc. 901 in class
- Koniniklijke Philips N.V. 836 in class
- Fisher & Paykel Healthcare Limited 773 in class
- Covidien LP 726 in class
- Terumo Kabushiki Kaisha 724 in class
- ResMed Pty Ltd 682 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Kindeva, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Kindeva ranks #230 of 3,490 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (45 here).
Kindeva's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
45 Top 24% higher than 76% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 4 | 12.1% |
| 2021 | 8 | 24.2% |
| 2022 | 9 | 27.3% |
| 2023 | 6 | 18.2% |
| 2024 | 2 | 6.1% |
| 2025partial year | 4 | 12.1% |
Which technologies does Kindeva Drug Delivery L.P. patent most?
Top 13 of 13 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Kindeva Drug Delivery L.P.'s patent record in context - here's where to go next.
- Kindeva Drug Delivery L.P.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 93.9% of its portfolio - see every assignee active in that class. Explore A61M
- Ranked #9,540 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Kindeva Drug Delivery L.P. against Kind Consumer Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 44.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.